BioMarin Pharmaceutical

BioMarin Pharmaceutical is a biopharmaceutical company that develops enzyme-based therapies for chronic genetic diseases. The company has three highly promising orphan drugs in its pipeline, one of which is the gene therapy for hemophilia A, valoctocogene roxaparvovec (BMN 270).